Rapid Micro Biosystems (RPID) Research & Development (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Research & Development data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 22.1% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (changed 0.07% YoY), and the FY2025 full-year result was $12.1 million, down 8.93% from the prior year.
• Research & Development climbed to $3.4 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.1 million in Q4 2022 to a low of $1.7 million in Q4 2025.
• A 5-year average of $3.2 million and a median of $3.4 million in 2026 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 60.97% in 2022 and tumbled 35.52% in 2023, its largest moves.
• Tracing RPID's Research & Development over 5 years: stood at $4.1 million in 2022, then plunged by 35.52% to $2.7 million in 2023, then declined by 22.11% to $2.1 million in 2024, then declined by 17.96% to $1.7 million in 2025, then jumped by 97.7% to $3.4 million in 2026.
• Business Quant data shows RPID's Research & Development at $3.4 million in Q1 2026, $1.7 million in Q4 2025, and $3.5 million in Q3 2025.